Show simple item record

dc.contributor.authorBalaban, Muhsinen_US
dc.contributor.authorOzkaptan, Orkunten_US
dc.contributor.authorSevinc, Cuneyden_US
dc.contributor.authorBoz, Mustafa Yucelen_US
dc.contributor.authorHoruz, Rahimen_US
dc.contributor.authorKafkasli, Alperen_US
dc.contributor.authorCanguven, Onderen_US
dc.date.accessioned2020-08-30T20:06:23Z
dc.date.available2020-08-30T20:06:23Z
dc.date.issued2020
dc.identifier.citationBalaban, M., Ozkaptan, O., Sevinc, C., Boz, M. Y., Horuz, R., Kafkasli, A., & Canguven, O. (2020). Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases. International braz j urol, 46(1), 60-66.en_US
dc.identifier.issn1677-5538
dc.identifier.issn1677-6119
dc.identifier.urihttps://doi.org/10.1590/S1677-5538.IBJU.2019.0257
dc.identifier.urihttps://hdl.handle.net/20.500.12713/497
dc.description.abstractObjectives: To investigate the characteristics of cases of NIH category I acute prostatitis developed after transrectal prostate biopsy and clarifiy the risk factors and preventive factors. Materials and Methods: We retrospectively reviewed the medical records of 3.479 cases of transrectal ultrasound-guided needle biopsies performed with different prophylactic antibiotherapy regimens at two different institutions between January 2011 and February 2016. The patients of Group I have received ciprofloxacin (n=1.523, 500mg twice daily) and the patients of Group II have received ciprofloxacin plus ornidazole (n=1.956, 500mg twice daily) and cleansing enema combination as prophylactic antibiotherapy. The incidence, clinical features and other related microbiological and clinical data, were evaluated. Results: Mean age was 62.38 +/- 7.30 (47-75), and the mean prostate volume was 43.17 +/- 15.20 (21-100) mL. Of the 3.479 patients, 39 (1.1%) developed acute prostatitis after the prostate biopsy procedure. Of the 39 cases of acute prostatitis, 28/3.042 occurred after the first biopsy and 11/437 occurred after repeat biopsy (p=0.038). In Group I, 22 of 1.523 (1.4%) patients developed acute prostatitis. In Group II, 17 of 1.959 (0.8%) patients developed acute prostatitis. There was no statistical difference between the two groups according to acute prostatitis rates (X2=2.56, P=0.11). Further, hypertension or DM were not related to the development of acute prostatitis (P=0.76, X2=0.096 and P=0.83, X2=0.046, respectively). Conclusions: Repeat biopsy seems to increase the risk of acute prostatitis, while the use of antibiotics effective for anaerobic pathogens seems not to be essential yet.en_US
dc.language.isoengen_US
dc.publisherBrazilian Soc Urolen_US
dc.relation.isversionof10.1590/S1677-5538.IBJU.2019.0257en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectProstatitisen_US
dc.subjectProstateen_US
dc.subjectBiopsyen_US
dc.titleAcute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy casesen_US
dc.typearticleen_US
dc.contributor.departmentİstinye Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorSevinc, Cuneyden_US
dc.identifier.volume46en_US
dc.identifier.issue1en_US
dc.identifier.startpage60en_US
dc.identifier.endpage66en_US
dc.relation.journalInternational Braz J Urolen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.description.wospublicationidWOS:000503407700009en_US
dc.description.pubmedpublicationid31851459en_US
dc.description.wosqualityQ4en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record